Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Atelocollagen & Hyaluronic Acid Correlation With Enhancement of Rotator Cuff Healing: Synergistic Effect?

NCT07285746 · tracked via the Priya Life Science South Korea tracker
Sponsor
Hallym University Dongtan Sacred Heart Hospital
Phase
Not applicable
Started
2020-03-02
Last updated
2026-02-11

Condition(s) studied

Rotator Cuff Tear

Investigational drug(s) / intervention(s)

Atelo collagen injectionHyaluronic acid injection

Atelo collagen injection: Patients receive atelocollagen injection during arthroscopic rotator cuff repair.

Hyaluronic acid injection: Patients receive hyaluronic acid injection during arthroscopic rotator cuff repair.

Study summary

The purpose of this study is to analyze the correlation between the synergistic effects of atelocollagen and hyaluronic acid (HA) in enhancing rotator cuff healing postoperatively in patients undergoing rotator cuff repair surgery.The main questions it aims to answer are:

* Does atelo Collagen aid in the rotator cuff repair healing process?
* Does hyaluronic acid (HA) aid in the rotator cuff repair healing process?
* Does the combined use of atelo collagen and HA in the rotator cuff repair healing process have a synergistic effect?

The researchers will compare the use of atelo collagen and HA alone with no treatment to determine their effectiveness in rotator cuff healing.

Participants will:

* receive injections of atelo collagen or HA, either alone or in combination, during arthroscopic rotator cuff repair.
* visit the clinic for medical checkups and tests every 3 months, 6 months, 1 year, and 2 years.

Eligibility

Sex
ALL
Min age
40 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 40 and 75 years * Scheduled for arthroscopic surgery after an MRI confirmed a diagnosis of rotator cuff tear * Willing to participate and provide informed consent Exclusion Criteria: * Previous surgery on the affected shoulder * Severe glenohumeral arthritis (Hamada grade ≥ 3) * Neurological disorder affecting shoulder function * Massive rotator cuff tear (Tear size ≥ 5 cm)

Primary outcome measure(s)

  • Rotator cuff healing status — 6 and 24 months after surgery
    Assessed by MRI according to Sugaya classification \& cuff muscle atrophy ratio

Trial sites (1)

FacilityCityRegionStatus
Hallym University Dongtan Sacred Heart Hospital Hwaseong-si South Korea

More Hallym University Dongtan Sacred Heart Hospital trials in South Korea

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07285746 on ClinicalTrials.gov ↗ ← All trials in South Korea